Progress in the structural prediction of G protein-coupled receptors: D 3 receptor in complex with eticlopride

Proteins: Structure, Function and Bioinformatics

Volumn 79, Issue 6, 2011, Pages 1695-1703

  Obiol Pardo, Cristian ^a   López, Laura ^a   Pastor, Manuel ^a   Selent, Jana ^a  

^a UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

Blind prediction; Conformational analysis; D 3 receptor; DOCK2010 assessment; Docking; Eticlopride; GPCR; Homology modeling; Ligand binding; Scoring function

Indexed keywords

DOPAMINE 3 RECEPTOR; ETICLOPRIDE; G PROTEIN COUPLED RECEPTOR;

ALGORITHM; ARTICLE; COMPLEX FORMATION; COMPUTER MODEL; CRYSTAL STRUCTURE; DRUG CONFORMATION; DRUG RECEPTOR BINDING; DRUG STRUCTURE; LIGAND BINDING; MOLECULAR DOCKING; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN STRUCTURE; SEQUENCE HOMOLOGY; THREE DIMENSIONAL IMAGING;

BINDING SITES; DOPAMINE ANTAGONISTS; HUMANS; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN CONFORMATION; RECEPTORS, DOPAMINE D3; SALICYLAMIDES; STRUCTURAL HOMOLOGY, PROTEIN;

EID: 79955721878     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.23021     Document Type: Article

References (23)

1. Lagerstrom MC, Schioth HB. Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat Rev Drug Discov 2008; 7: 339-357.
2. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Le Trong I, Teller DC, Okada T, Stenkamp RE, Yamamoto M, Miyano M. Crystal structure of rhodopsin: a G protein-coupled receptor. Science 2000; 289: 739-745.
3. Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, Choi HJ, Kuhn P, Weis WI, Kobilka BK, Stevens RC. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 2007; 318: 1258-1265.
4. Rosenbaum DM, Cherezov V, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, Choi HJ, Yao XJ, Weis WI, Stevens RC, Kobilka BK. GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function. Science 2007; 318: 1266-1273.
5. Warne T, Serrano-Vega MJ, Baker JG, Moukhametzianov R, Edwards PC, Henderson R, Leslie AG, Tate CG, Schertler GF. Structure of a beta1-adrenergic G-protein-coupled receptor. Nature 2008; 454: 486-491.
6. Jaakola VP, Griffith MT, Hanson MA, Cherezov V, Chien EY, Lane JR, Ijzerman AP, Stevens RC. The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science 2008; 322: 1211-1217.
7. Katritch V, Rueda M, Lam PC, Yeager M, Abagyan R. GPCR 3D homology models for ligand screening: lessons learned from blind predictions of adenosine A2a receptor complex. Proteins 2010; 78: 197-211.
8. Michino M, Abola E, GPCR Dock 2008 participants, Brooks CL, III, Dixon JS, Moult J, Stevens RC. Community-wide assessment of GPCR structure modelling and ligand docking: GPCR Dock 2008. Nat Rev Drug Discov 2009; 8: 455-463.
9. Chien EY, Liu W, Zhao Q, Katritch V, Han GW, Hanson MA, Shi L, Newman AH, Javitch JA, Cherezov V, Stevens RC. Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist. Science 2010; 330: 1091-1095.
10. Joyce JN, Millan MJ. Dopamine D3 receptor antagonists as therapeutic agents. Drug Discov Today 2005; 10: 917-925.
11. van de Waterbeemd H, Testa B. Theoretical conformational studies on some dopamine antagonistic benzamide drugs: 3-pyrrolidyl- and 4-piperidyl derivatives. J Med Chem 1983; 26: 203-207.
12. de Paulis T, Kumar Y, Johansson L, Rämsby S, Florvall L, Hall H, Angeby-Möller K, Ogren SO. Potential neuroleptic agents. 3. Chemistry and antidopaminergic properties of substituted 6-methoxysalicylamides. J Med Chem 1985; 28: 1263-1269.
13. Martelle JL, Nader MA. A review of the discovery, pharmacological characterization, and behavioral effects of the dopamine D2-like receptor antagonist eticlopride. CNS Neurosci Ther 2008; 14: 248-262.
14. López L, Selent J, Ortega R, Masaguer CF, Domínguez E, Areias F, Brea J, Loza MI, Sanz F, Pastor M. Synthesis, 3D-QSAR, and structural modeling of benzolactam derivatives with binding affinity for the D(2) and D(3) receptors. ChemMedChem 2010; 5: 1300-1317.
15. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. The CLUSTAL-X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997; 25: 4876-4882.
16. Zhao Y, Lu X, Yang CY, Huang Z, Fu W, Hou T, Zhang J. Computational modeling toward understanding agonist binding on dopamine 3. J Chem Inf Model 2010; 50: 1633-1643.
17. Sali A, Blundell TL. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 1993; 234: 779-815.
18. Wang J, Cieplak P, Kollman PA. How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules? J Comput Chem 2000; 21: 1049-1074.
19. Laskowski RA, MacArthur MW, Moss DS, Thornton JM. PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr 1993; 26: 283-291.
20. Selent J, Sanz F, Pastor M, De Fabritiis G. Induced effects of sodium ions on dopaminergic G-protein coupled receptors. PLoS Comput Biol 2010; 6: e1000884.
21. Verdonk ML, Cole JC, Hartshorn MJ, Murray CW, Taylor RD. Improved protein-ligand docking using GOLD. Proteins 2003; 52: 609-623.
22. Butler KT, Luque FJ, Barril X. Toward accurate relative energy predictions of the bioactive conformation of drugs. J Comput Chem 2009; 30: 601-610.
23. Selent J, Bauer-Mehren A, López L, Loza MI, Sanz F, Pastor M. A novel multilevel statistical method for the study of the relationships between multireceptorial binding affinity profiles and in vivo endpoints. Mol Pharmacol 2010; 77: 149-158.